Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 6021: Lutetium-177 (¹⁷⁷Lu) radiolabeled engineered antibody fragment against human prostate stem cell antigen (hPSCA) demonstrates targeting and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC)

Bao Ying Chen, Masoud Farshbaf, Felix B. Salazar, Saad N. Ahmed, Sunidhi Jaiswal, Jennifer Chean, Anakim Sherman, Teresa Hong, Paul J. Yazaki, Tove Olafsen, Kirstin A. Zettlitz, Anna M. Wu

Cancer Res (2024) 84 (6_Supplement): 6021.

https://doi.org/10.1158/1538-7445.AM2024-6021

Published: 22 March 2024

View article titled, Abstract 6021: Lutetium-177 (177Lu) radiolabeled engineered antibody fragment against human prostate stem cell antigen (hPSCA) demonstrates targeting and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC)

Journal Articles

Abstract A088: Radiopharmaceutical therapy for pancreatic cancer: Engineered anti-prostate stem cell antigen (PSCA) antibody demonstrates targeted imaging and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC)

Bao Ying Chen, Saad N. Ahmed, Felix Salazar, Sunidhi Jaiswal, Masoud Farshbaf, Jennifer Chean, Anakim Sherman, Teresa Hong, Paul J. Yazaki, Tove Olafsen, Kirstin A. Zettlitz, Anna M. Wu

Cancer Res (2024) 84 (2_Supplement): A088.

https://doi.org/10.1158/1538-7445.PANCA2023-A088

Published: 16 January 2024

View article titled, Abstract A088: Radiopharmaceutical therapy for pancreatic cancer: Engineered anti-prostate stem cell antigen (PSCA) antibody demonstrates targeted imaging and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC)

Journal Articles

The PET-Tracer ⁸⁹Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment

Cancer Res (2020) 80 (13): 2903–2913.

https://doi.org/10.1158/0008-5472.CAN-19-3269

Published: 02 July 2020

View article titled, The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment

Includes: Supplementary data

Journal Articles

Abstract LB-188: Sensitivity of ⁸⁹Zr-labeled anti-CD8 minibody for PET imaging of infiltrating CD8+ T cells

Tove Olafsen, Ziyue Karen Jiang, Jason Romero, Charles Zamilpa, Filippo Marchioni, Green Zhang, Michael Torgov, Daulet Satpayev, Jean M. Gudas

Cancer Res (2016) 76 (14_Supplement): LB-188.

https://doi.org/10.1158/1538-7445.AM2016-LB-188

Published: 15 July 2016

View article titled, Abstract LB-188: Sensitivity of 89Zr-labeled anti-CD8 minibody for PET imaging of infiltrating CD8+ T cells

Journal Articles

Abstract LB-163: Development of an immunoPET tracer for imaging human CD8+ T cells

Tove Olafsen, David Ho, Eric Epin, Green Zhang, Michael Torgov, Charlie Beigarten, Giti Agahi, Edward Cabral, Anna M. Wu, Jean M. Gudas

Cancer Res (2014) 74 (19_Supplement): LB-163.

https://doi.org/10.1158/1538-7445.AM2014-LB-163

Published: 01 October 2014

View article titled, Abstract LB-163: Development of an immunoPET tracer for imaging human CD8+ T cells

Journal Articles

Abstract LB-351: Evaluation of two engineered antibody fragments derived from a human CD20 antibody as tracers for immunoPET .

Jean Gudas, Tove Olafsen, David Ho, Derek Bartlett, Arye Lipman, Jean Gudas, Katy Sorenson, Jennifer Keppler, Christian Behrenbruch, Anna Wu, Sharon Ashworth, Jan Passchier, Roger Gunn, Paul Matthews

Cancer Res (2013) 73 (8_Supplement): LB-351.

https://doi.org/10.1158/1538-7445.AM2013-LB-351

Published: 15 April 2013

View article titled, Abstract LB-351: Evaluation of two engineered antibody fragments derived from a human CD20 antibody as tracers for immunoPET .

Journal Articles

Abstract 4283: Evaluation of PSCA-specific minibody for in vivo imaging

Chau P. Tran, Scott Knowles, Tove Olafsen, Eric J. Lepin, Anna M. Wu, Robert E. Reiter

Cancer Res (2011) 71 (8_Supplement): 4283.

https://doi.org/10.1158/1538-7445.AM2011-4283

Published: 15 April 2011

View article titled, Abstract 4283: Evaluation of PSCA-specific minibody for in vivo imaging

Journal Articles

In vivo detection of prostate stem cell antigen (PSCA)-expressing xenografts using ¹²⁴I-labeled engineered antibody fragments

Jeffrey Leyton, Eric Lepin, Tove Olafsen, Yu Zhou, Scott Hahm, James Marks, Robert Reiter, Anna Wu

Cancer Res (2008) 68 (9_Supplement): 4901.

Published: 01 May 2008

View article titled, In vivo detection of prostate stem cell antigen (PSCA)-expressing xenografts using 124I-labeled engineered antibody fragments

Journal Articles

Radioiodinated versus Radiometal-Labeled Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments: Optimal Pharmacokinetics for Therapy

Vania Kenanova, Tove Olafsen, Lawrence E. Williams, Nora H. Ruel, Jeffrey Longmate, Paul J. Yazaki, John E. Shively, David Colcher, Andrew A. Raubitschek, Anna M. Wu

Cancer Res (2007) 67 (2): 718–726.

https://doi.org/10.1158/0008-5472.CAN-06-0454

Published: 18 January 2007

View article titled, Radioiodinated versus Radiometal-Labeled Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments: Optimal Pharmacokinetics for Therapy

Journal Articles

Optimizing Radiolabeled Engineered Anti-p185^HER2 Antibody Fragments for In vivo Imaging

Tove Olafsen, Vania E. Kenanova, Gobalakrishnan Sundaresan, Anne-Line Anderson, Desiree Crow, Paul J. Yazaki, Lin Li, Michael F. Press, Sanjiv S. Gambhir, Lawrence E. Williams, Jeffrey Y.C. Wong, Andrew A. Raubitschek, John E. Shively, Anna M. Wu

Cancer Res (2005) 65 (13): 5907–5916.

https://doi.org/10.1158/0008-5472.CAN-04-4472

Published: 01 July 2005

View article titled, Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments for In vivo Imaging

Includes: Supplementary data

Journal Articles

Biological activity and microPET imaging properties of chimeric and humanized anti-prostate stem cell antigen (PSCA) antibodies

Zhennan Gu, Tove Olafsen, Mark Sherman, Sherie L. Morrison, Anna M. Wu, Robert E. Reiter

Cancer Res (2005) 65 (9_Supplement): 164.

Published: 01 May 2005

View article titled, Biological activity and microPET imaging properties of chimeric and humanized anti-prostate stem cell antigen (PSCA) antibodies

Journal Articles

Engineered anti-CEA scFv-Fc antibody fragments tailored for pharmacokinetic and imaging properties

Vania E. Kenanova, Tove Olafsen, Gobalakrishnan Sundaresan, Murugesan Subbarayan, Lawrence E. Williams, John E. Shively, David Colcher, Sanjiv S. Gambhir, Andrew A. Raubitschek, Anna M. Wu

Cancer Res (2005) 65 (9_Supplement): 1243.

Published: 01 May 2005

View article titled, Engineered anti-CEA scFv-Fc antibody fragments tailored for pharmacokinetic and imaging properties

Journal Articles

MicroPET imaging of breast cancer xenografts with anti-p185^HER2 minibody and scFv-Fc antibody fragments

Tove Olafsen, Vania E. Kenanova, Gobalakrishnan Sundaresan, Anne-Line Anderson, Michael F. Press, Sanjiv S. Gambhir, Lawrence E. Williams, Andrew A. Raubitschek, John E. Shively, Anna M. Wu

Cancer Res (2005) 65 (9_Supplement): 899–900.

Published: 01 May 2005

View article titled, MicroPET imaging of breast cancer xenografts with anti-p185HER2 minibody and scFv-Fc antibody fragments

Journal Articles

Tailoring the Pharmacokinetics and Positron Emission Tomography Imaging Properties of Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments

Vania Kenanova, Tove Olafsen, Desiree M. Crow, Gobalakrishnan Sundaresan, Murugesan Subbarayan, Nora H. Carter, David N. Ikle, Paul J. Yazaki, Arion F. Chatziioannou, Sanjiv S. Gambhir, Lawrence E. Williams, John E. Shively, David Colcher, Andrew A. Raubitschek, Anna M. Wu

Cancer Res (2005) 65 (2): 622–631.

https://doi.org/10.1158/0008-5472.622.65.2

Published: 03 February 2005

View article titled, Tailoring the Pharmacokinetics and Positron Emission Tomography Imaging Properties of Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments

NARROW

Abstract 6021: Lutetium-177 (¹⁷⁷Lu) radiolabeled engineered antibody fragment against human prostate stem cell antigen (hPSCA) demonstrates targeting and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC)

Abstract A088: Radiopharmaceutical therapy for pancreatic cancer: Engineered anti-prostate stem cell antigen (PSCA) antibody demonstrates targeted imaging and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC)

The PET-Tracer ⁸⁹Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment

Abstract LB-188: Sensitivity of ⁸⁹Zr-labeled anti-CD8 minibody for PET imaging of infiltrating CD8+ T cells

Abstract LB-163: Development of an immunoPET tracer for imaging human CD8+ T cells

Abstract LB-351: Evaluation of two engineered antibody fragments derived from a human CD20 antibody as tracers for immunoPET .

Abstract 4283: Evaluation of PSCA-specific minibody for in vivo imaging

In vivo detection of prostate stem cell antigen (PSCA)-expressing xenografts using ¹²⁴I-labeled engineered antibody fragments

Radioiodinated versus Radiometal-Labeled Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments: Optimal Pharmacokinetics for Therapy

Optimizing Radiolabeled Engineered Anti-p185^HER2 Antibody Fragments for In vivo Imaging

Biological activity and microPET imaging properties of chimeric and humanized anti-prostate stem cell antigen (PSCA) antibodies

Engineered anti-CEA scFv-Fc antibody fragments tailored for pharmacokinetic and imaging properties

MicroPET imaging of breast cancer xenografts with anti-p185^HER2 minibody and scFv-Fc antibody fragments

Tailoring the Pharmacokinetics and Positron Emission Tomography Imaging Properties of Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only